Kintara Therapeutics Inc (KTRA)
NASDAQ
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | -124.371 | -151.008 | -146.31 | -261.935 | -503.659 | -153.681 | -150.74 | -166.997 |
Return on Equity (%) | -155.132 | -188.364 | -219.643 | -819.283 | -765.474 | -202.547 | -239.805 | -378.832 |
Return on Invested Capital (%) | -145.2 | -185.6 | -226.479 | -856.69 | -481.93 | -249.582 | -298.126 | -376.604 |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | 0.011 | -0.043 | -0.784 | -0.396 | -0.133 | -0.012 | -5.859 | -0.117 |
Earnings Per Share | -0.611 | -0.493 | -2.117 | -0.797 | -1.268 | -0.346 | -8.876 | -0.154 |
Cash Per Share | 0.454 | 0.26 | 0.969 | 0.209 | 0.322 | 0.18 | 0.907 | 0.089 |
Working Capital Per Share | 0.453 | 0.235 | 0.509 | 0.015 | 0.275 | 0.141 | 0.111 | 0.059 |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | -0.557 | -0.485 | -2.096 | -0.796 | -1.17 | -0.346 | -8.658 | -0.15 |
EBITDA Per Share | -0.557 | -0.485 | -2.096 | -0.796 | -1.17 | -0.346 | -8.658 | -0.15 |
Free Cash Flow Per Share | -0.611 | -0.493 | -2.122 | -0.798 | -1.268 | -0.347 | -8.775 | -0.154 |
Fin d'année 30 Juin 2024 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Actions en circulation | 14,51M | 22,97M | 3,84M | 11,46M | 32,74M | 65,53M | N/A | N/A |
Fin d'année 30 Juin 2024 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 1,67M | N/A | N/A | 3,39M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Capitalisation boursière | 419,63M |
Ratio cours/bénéfice | -27,18 |
Ratio prix/ventes | 0 |
Ratio prix/liquidités | 47,05 |
Ratio prix/valeur comptable | 61,48 |
Rendement de dividende | - |
Actions en circulation | 55,66M |
Volume moyen (1 semaine) | 0 |
Volume moyen (1 mois) | 0 |
Variation sur 52 semaines | 68,54% |
Plus haut sur 52 semaines | 14,595 |
Plus bas sur 52 semaines | 2,835 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales